TSLA
Tesla
-- 412.380 NVDA
NVIDIA
-- 147.220 PLTR
Palantir
-- 78.980 AAPL
Apple
-- 223.660 TEM
Tempus AI
-- 54.840 
$60 Degrees Pharmaceuticals (SXTP.US)$ high volume but isn't...
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
hello! my name is John. I'm here just for fun and learning. don't be afraid to ask questions. good luck to you all.
229
Followers
426
Following
975
Visitors
Follow
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks
Michael McCarthy CCO
Jan 3 11:57
Ask a strategist - Trump's first day
ProperMicheleV : u r 100% correct. Tanefoquine is not the answer to chronic babesiosis. However, this company is somehow connected to the CDC & important legislators in DC. Their HQ is located steps away from all the important pharma players in DC & the senate. That being said, at some point, after Yale, Tufts & NC college of Veterinary Medicine, publish the pps will
. We all know those academic institutions are paid to provide answers that benefit whose paying them, not only by corrupt grants but flat fees for their research. Long story short.... they have a dog in the fight. There should be laws against that. If I give 250k to Harvard Business Review, I can get a ham sandwich in pill form touted as the next "cure all". There is total catastrophic failure on the horizon. & I feel GSK is still involved with Tanefoquine aka Krintafel. Google it.